ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHO TM Transient Expression System. Due to its enhanced plasmid ...

To enhance CAR T therapies, scientists are actively studying TCR signaling and T-cell exhaustion mechanisms to improve CAR T persistence and function. Additionally, there is a growing trend towards ...

Practical Solutions to Expression Problems Include RNA Interference and Glycoengineering of CHO Systems Like a train that consists of a particular sequence of cars, from locomotive to caboose, ...

CAMBRIDGE, England--(BUSINESS WIRE)--Horizon Discovery Group plc (LSE: HZD) (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell ...

Horizon Discovery Group plc (“Horizon”, “the Company” or “the Group”), a global leader in the application of gene editing and gene modulation for cell line engineering, today announced that it will ...